BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26259251)

  • 1. β-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition.
    Barrott JJ; Illum BE; Jin H; Zhu JF; Mosbruger T; Monument MJ; Smith-Fry K; Cable MG; Wang Y; Grossmann AH; Capecchi MR; Jones KB
    Oncotarget; 2015 Sep; 6(26):22758-66. PubMed ID: 26259251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
    Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
    Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paracrine osteoprotegerin and β-catenin stabilization support synovial sarcomagenesis in periosteal cells.
    Barrott JJ; Illum BE; Jin H; Hedberg ML; Wang Y; Grossmann A; Haldar M; Capecchi MR; Jones KB
    J Clin Invest; 2018 Jan; 128(1):207-218. PubMed ID: 29202462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis.
    Jones KB; Barrott JJ; Xie M; Haldar M; Jin H; Zhu JF; Monument MJ; Mosbruger TL; Langer EM; Randall RL; Wilson RK; Cairns BR; Ding L; Capecchi MR
    Oncogene; 2016 Sep; 35(38):5021-32. PubMed ID: 26947017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Wnt pathway in synovial sarcoma models.
    Barham W; Frump AL; Sherrill TP; Garcia CB; Saito-Diaz K; VanSaun MN; Fingleton B; Gleaves L; Orton D; Capecchi MR; Blackwell TS; Lee E; Yull F; Eid JE
    Cancer Discov; 2013 Nov; 3(11):1286-301. PubMed ID: 23921231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma.
    Saito T; Nagai M; Ladanyi M
    Cancer Res; 2006 Jul; 66(14):6919-27. PubMed ID: 16849535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synovial sarcoma translocation protein SYT-SSX2 recruits beta-catenin to the nucleus and associates with it in an active complex.
    Pretto D; Barco R; Rivera J; Neel N; Gustavson MD; Eid JE
    Oncogene; 2006 Jun; 25(26):3661-9. PubMed ID: 16462762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fusion protein SS18-SSX1 employs core Wnt pathway transcription factors to induce a partial Wnt signature in synovial sarcoma.
    Cironi L; Petricevic T; Fernandes Vieira V; Provero P; Fusco C; Cornaz S; Fregni G; Letovanec I; Aguet M; Stamenkovic I
    Sci Rep; 2016 Feb; 6():22113. PubMed ID: 26905812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.
    Nielsen TO; Poulin NM; Ladanyi M
    Cancer Discov; 2015 Feb; 5(2):124-34. PubMed ID: 25614489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdependence of SS18-SSX-driven YAP1 and β-Catenin Activation in Synovial Sarcoma.
    Isfort I; Berthold R; Heinst L; Wardelmann E; Larsson O; Trautmann M; Hartmann W
    Mol Cancer Res; 2023 Jun; 21(6):535-547. PubMed ID: 36920288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation.
    de Bruijn DR; Allander SV; van Dijk AH; Willemse MP; Thijssen J; van Groningen JJ; Meltzer PS; van Kessel AG
    Cancer Res; 2006 Oct; 66(19):9474-82. PubMed ID: 17018603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SS18-SSX2 and the mitochondrial apoptosis pathway in mouse and human synovial sarcomas.
    Jones KB; Su L; Jin H; Lenz C; Randall RL; Underhill TM; Nielsen TO; Sharma S; Capecchi MR
    Oncogene; 2013 May; 32(18):2365-71, 2375.e1-5. PubMed ID: 22797074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling synovial sarcoma metastasis in the mouse: PI3'-lipid signaling and inflammation.
    Barrott JJ; Kafchinski LA; Jin H; Potter JW; Kannan SD; Kennedy R; Mosbruger T; Wang WL; Tsai JW; Araujo DM; Liu T; Capecchi MR; Lazar AJ; Jones KB
    J Exp Med; 2016 Dec; 213(13):2989-3005. PubMed ID: 27956588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF Destruction.
    Li J; Mulvihill TS; Li L; Barrott JJ; Nelson ML; Wagner L; Lock IC; Pozner A; Lambert SL; Ozenberger BB; Ward MB; Grossmann AH; Liu T; Banito A; Cairns BR; Jones KB
    Cancer Discov; 2021 Oct; 11(10):2620-2637. PubMed ID: 34078620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synovial sarcoma is a stem cell malignancy.
    Naka N; Takenaka S; Araki N; Miwa T; Hashimoto N; Yoshioka K; Joyama S; Hamada K; Tsukamoto Y; Tomita Y; Ueda T; Yoshikawa H; Itoh K
    Stem Cells; 2010 Jul; 28(7):1119-31. PubMed ID: 20518020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
    Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The transcription factor LEF-1 induces an epithelial-mesenchymal transition in MDCK cells independent of β-catenin.
    Kobayashi W; Ozawa M
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):133-8. PubMed ID: 24269234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling synovial sarcoma: timing is everything.
    Davis SR; Meltzer PS
    Cancer Cell; 2007 Apr; 11(4):305-7. PubMed ID: 17418406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition.
    Zhang L; Liu H; Mu X; Cui J; Peng Z
    Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28232512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.